close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

82.29 +1.57 (+1.94%)
Official Closing Price Updated: 4:10 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
Alcon Reports First Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Results of 2023 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Publishes Agenda for 2023 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon to Host 2023 Capital Markets Day
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon Reports Fourth Quarter and Full Year 2022 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Prices US$1.3 Billion Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Reports Third Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
From Alcon Inc. Investors
Via Business Wire
News headline image
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of 
Via Spotlight Growth
News headline image
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Reports Second Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon Prices EUR 500.0 Million Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Reports First Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Results of 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon to Deliver Robust Scientific Program at ASCRS 2022
From Alcon Inc. Investors
Via Business Wire
News headline image
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
From Alcon Inc. Corporate
Via Business Wire
News headline image
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
From Alcon Inc. Corporate
Via Business Wire
News headline image
Alcon Publishes Agenda for 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today